Individuals with cystic fibrosis adults as well infants and children have long struggled to gain and maintain their weight. But how has the current widespread use of highly effective modulator treatments HEMT changed that situation? Thats the foc
The advent of triple CFTR modulator therapy ETI (elexacaftor/tezacaftor/ivacaftor) poses a number of clinical questions. Are three agents really better than two? For which patients, in what circumstances? What does the CF Team need to understand to en
Managing pulmonary exacerbations in people with cystic fibrosis: is there high-grade evidence to support best practices? How helpful is the most current guidance? Does the recent research challenge the current standard of care? Join us for this
Race and ethnicity. How do they affect a patients ability to receive a timely and accurate cystic fibrosis diagnosis? How do the social determinants of health limit access to appropriate CF treatment and produce poorer outcomes? Thats what were he
Pancreatic insufficiency.In children with CF, its been associated with delayed development and increased odds of developingsevere lung disease.Howcanitbe more accuratelydiagnosed?And what does the evidence say about the effects oftreatment with
Effects of the COVID-19 pandemic on CF treatment.
Cystic Fibrosis and COVID-19 with Marianne Muhlebach, MD
Cystic Fibrosis and COVID-19 with Robert W. Miller, MD
Cystic Fibrosis and COVID-19 with John J. LiPuma, MD
Strategies to initiate discussions related to sexual and reproductive health concerns with women with CF.